Form 4: Fulgent Genetics President and COO Jian Xie Reports Stock Transaction

Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Summary

• On July 26, 2024, Jian Xie, the President and COO of Fulgent Genetics, Inc., reported a transaction involving common stock.
• 4,345 shares were withheld to satisfy tax obligations arising from the vesting of restricted stock units granted on November 7, 2022.
• The price per share for the transaction was $23.66.
• Following the transaction, Mr. Xie directly owns 350,198 shares of common stock.
• Mr. Xie also indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust, dated January 27, 2010, for which he serves on the investment committee.

Sentiment

Score: 5

Explanation: This is a neutral report of a routine stock transaction related to tax obligations. It doesn't indicate positive or negative sentiment.

Industry Context

This is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the stock ownership of company executives.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine tax-related stock withholding.

Key Dates